Ampio Pharmaceuticals (AMEX:AMPE) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 100 percent decrease over losses of $(0.02) per share from the same period last year.
UPDATE: Ampio Pharmaceuticals Q4 Adj. EPS $(0.04) Misses $(0.02) Estimate
Ampio Pharmaceuticals (AMEX:AMPE) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 100 percent decrease over losses of $(0.02) per share from
Related Posts
WISeKey Shares Move Higher; Co Highlights HIRO Cybersecurity Knowledge Automation
WISeKey combats cybercrime with HIRO™ Cybersecurity Knowledge Automation, the first ever integrated cybersecurity automation solution which uses Advance AI to mimic humans for learning and applying
Barclays Initiates Coverage On XPeng with Overweight Rating
Barclays analyst Jiong Shao initiates coverage on XPeng (NYSE:XPEV) with a Overweight rating.